The Economic Burden of Psoriasis in Korea
- Author:
Byeol HAN
1
;
Ki-Heon JEONG
;
Tae-Gyun KIM
;
Kwang Joong KIM
;
Dong Hyun KIM
;
Byung-Soo KIM
;
Kyung Duck PARK
;
Chul Jong PARK
;
Hai-Jin PARK
;
Chul Hwan BANG
;
Bong Seok SHIN
;
Sang Woong YOUN
;
Jai Il YOUN
;
Ju Hee LEE
;
Kyung Eun JUNG
;
Yong Beom CHOE
;
Seong-jin JO
Author Information
1. Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea
- Publication Type:Original Article
- From:Korean Journal of Dermatology
2021;59(5):321-331
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:Psoriasis is a chronic disease that can have accompanying comorbidities including arthritis, metabolic syndrome, and cardiovascular diseases. Patients with psoriasis tend to frequently visit medical institutions, and their economic burden for medical services is high.
Objective:To investigate the economic burden of psoriasis in Korea.
Methods:The Korean Society for Psoriasis conducted a multi-center field survey of the patients and analyzed the national insurance claim data. Also, we discussed the medical environment of psoriasis in Korea based on the results.
Results:The economic burden of psoriasis patients is substantial and varied by the type of medical institute. Patients also paid the indirect and intangible medical costs. Biological agents, which is used in patients with severe psoriasis, led to an increase in the cost.
Conclusion:This is the first study to estimate the economic burden of psoriasis in Korea comprehensively. To improve the medical environment of psoriasis and alleviate the burden of patients, discussion on the more efficient health policy and medical insurance criteria for psoriasis would be needed.
